Skip to main navigation
Search
Deciphera Pharmaceuticals, Inc.

main-navigation

  • About Us
    • Overview
    • Management
    • Board of Directors
    • Advisors
  • Our Pipeline
    • Overview
    • Ripretinib (DCC-2618)
    • Rebastinib
    • DCC-3014
  • Our Focus on Patients
    • Our Focus on Patients and Families
    • Gastrointestinal Stromal Tumors (GIST)
    • Systemic Mastocytosis
    • Breast Cancer
    • Tenosynovial Giant Cell Tumors (TGCT)
  • Our Research
    • Kinases in Cancer
    • Our Kinase Switch Control Platform
    • Presentations & Publications
  • Our Workplace
    • Our Culture and Values
    • Join our Team
  • Investors
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • Analyst Coverage
    • Press Releases
    • Deciphera in the News
    • Events & Presentations
    • Financial Information
      • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Management
      • Board of Directors
    • Investor Resources
      • FAQs
      • Contact IR
      • Email Alerts
  • Contact

Investors
»

ir-nav

  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
  • Analyst Coverage
  • Press Releases
  • Deciphera in the News
  • Events & Presentations
  • Financial Information
    • SEC Filings
  • Corporate Governance
    • Documents & Charters
    • Management
    • Board of Directors
  • Investor Resources
    • FAQs
    • Contact IR
    • Email Alerts

RSS Feeds

RSS Feeds

RSS (Really Simple Syndication) feeds provide an easy way to keep up with news and information about our company. Most web browsers have built in RSS readers, or you can use our feeds in an RSS reader or aggregator.

Latest News Releases

Latest SEC Filings

Recent Events


toolkit

  • Print

    Print

  • Email

    Email

  • RSS Feeds

    RSS Feeds

  • Email Alerts

    Email Alerts

  • Contact IR

    Contact IR


© 2021 Deciphera Pharmaceuticals, Inc. Deciphera, Deciphera Pharmaceuticals, and the Deciphera logo are trademarks of Deciphera Pharmaceuticals, LLC.

footer-nav

  • Terms of Use
  • Privacy Policy

main-navigation

  • About Us
    • Overview
    • Management
    • Board of Directors
    • Advisors
  • Our Pipeline
    • Overview
    • Ripretinib (DCC-2618)
    • Rebastinib
    • DCC-3014
  • Our Focus on Patients
    • Our Focus on Patients and Families
    • Gastrointestinal Stromal Tumors (GIST)
    • Systemic Mastocytosis
    • Breast Cancer
    • Tenosynovial Giant Cell Tumors (TGCT)
  • Our Research
    • Kinases in Cancer
    • Our Kinase Switch Control Platform
    • Presentations & Publications
  • Our Workplace
    • Our Culture and Values
    • Join our Team
  • Investors
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • Analyst Coverage
    • Press Releases
    • Deciphera in the News
    • Events & Presentations
    • Financial Information
      • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Management
      • Board of Directors
    • Investor Resources
      • FAQs
      • Contact IR
      • Email Alerts
  • Contact